These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 21951976)
21. Funding for dementia research but cuts to dementia care? Aust Nurs Midwifery J; 2014 Sep; 22(3):5. PubMed ID: 25289430 [No Abstract] [Full Text] [Related]
22. The relationship between government research funding and the cancer burden in South Korea: implications for prioritising health research. Jung YL; Yoo HS; Kim ES Health Res Policy Syst; 2019 Dec; 17(1):103. PubMed ID: 31870382 [TBL] [Abstract][Full Text] [Related]
23. Smoking-related diseases: the importance of COPD. Zaher C; Halbert R; Dubois R; George D; Nonikov D Int J Tuberc Lung Dis; 2004 Dec; 8(12):1423-8. PubMed ID: 15636487 [TBL] [Abstract][Full Text] [Related]
24. The burden of health care costs for patients with dementia in the last 5 years of life. Kelley AS; McGarry K; Gorges R; Skinner JS Ann Intern Med; 2015 Nov; 163(10):729-36. PubMed ID: 26502320 [TBL] [Abstract][Full Text] [Related]
25. Funding of headache research in Europe. Olesen J; Lekander I; Andlin-Sobocki P; Jönsson B Cephalalgia; 2007 Sep; 27(9):995-9. PubMed ID: 17727472 [TBL] [Abstract][Full Text] [Related]
26. Government and charity funding of cancer research: public preferences and choices. Shah KK; Sussex J; Hernandez-Villafuerte K Health Res Policy Syst; 2015 Sep; 13():38. PubMed ID: 26335693 [TBL] [Abstract][Full Text] [Related]
27. Cost of cardiovascular diseases in the United Kingdom. Luengo-Fernández R; Leal J; Gray A; Petersen S; Rayner M Heart; 2006 Oct; 92(10):1384-9. PubMed ID: 16702172 [TBL] [Abstract][Full Text] [Related]
28. Public funding for medical research in relation to the burden of disease caused by cardiovascular diseases and neoplasms in Germany. Krone M; Dufner V; Wagner M; Gelbrich G; Ertl G; Heuschmann PU Clin Res Cardiol; 2018 Sep; 107(9):737-744. PubMed ID: 29654436 [TBL] [Abstract][Full Text] [Related]
29. The macroeconomics of dementia--will the world economy get Alzheimer's disease? Banerjee S Arch Med Res; 2012 Nov; 43(8):705-9. PubMed ID: 23085453 [TBL] [Abstract][Full Text] [Related]
30. Burden of disease, research funding and innovation in the UK: Do new health technologies reflect research inputs and need? Ward D; Martino O; Packer C; Simpson S; Stevens A J Health Serv Res Policy; 2013 Apr; 18(1 Suppl):7-13. PubMed ID: 27552774 [TBL] [Abstract][Full Text] [Related]
31. Worldwide under-funding of stroke research. Pendlebury ST Int J Stroke; 2007 May; 2(2):80-4. PubMed ID: 18705958 [TBL] [Abstract][Full Text] [Related]
32. Comparing cutaneous research funded by the US National Institutes of Health (NIH) with the US skin disease burden. Hagstrom EL; Patel S; Karimkhani C; Boyers LN; Williams HC; Hay RJ; Weinstock MA; Armstrong AW; Dunnick CA; Margolis DJ; Dellavalle RP J Am Acad Dermatol; 2015 Sep; 73(3):383-91.e1. PubMed ID: 26051697 [TBL] [Abstract][Full Text] [Related]
33. [Economic burden of coronary heart disease and stroke attributable to hypertension in China]. Zhai Y; Hu JP; Kong LZ; Zhao WH; Chen CM Zhonghua Liu Xing Bing Xue Za Zhi; 2006 Sep; 27(9):744-7. PubMed ID: 17299955 [TBL] [Abstract][Full Text] [Related]
34. Funding for mental health research: the gap remains. Christensen H; Batterham PJ; Hickie IB; McGorry PD; Mitchell PB; Kulkarni J Med J Aust; 2011 Dec; 195(11-12):681-4. PubMed ID: 22171865 [TBL] [Abstract][Full Text] [Related]
35. Estimating the returns to UK publicly funded cancer-related research in terms of the net value of improved health outcomes. Glover M; Buxton M; Guthrie S; Hanney S; Pollitt A; Grant J BMC Med; 2014 Jun; 12():99. PubMed ID: 24930803 [TBL] [Abstract][Full Text] [Related]
36. Funding healthcare-associated infection research: a systematic analysis of UK research investments, 1997-2010. Head MG; Fitchett JR; Holmes AH; Atun R J Hosp Infect; 2014 Jun; 87(2):84-91. PubMed ID: 24815767 [TBL] [Abstract][Full Text] [Related]
37. National funding for mental health research in Finland, France, Spain and the United Kingdom. Hazo JB; Gandré C; Leboyer M; Obradors-Tarragó C; Belli S; McDaid D; Park AL; Maliandi MV; Wahlbeck K; Wykes T; van Os J; Haro JM; Chevreul K; Eur Neuropsychopharmacol; 2017 Sep; 27(9):892-899. PubMed ID: 28647453 [TBL] [Abstract][Full Text] [Related]
38. The use of epidemiological measures to estimate the impact of primary prevention interventions on CHD, stroke and cancer outcomes: experiences from Herefordshire, UK. Syed AM; Talbot-Smith A; Gemmell I J Epidemiol Glob Health; 2012 Sep; 2(3):111-24. PubMed ID: 23856450 [TBL] [Abstract][Full Text] [Related]
39. Rational allocation of Australia's research dollars: does the distribution of NHMRC funding by National Health Priority Area reflect actual disease burden? Mitchell RJ; McClure RJ; Olivier J; Watson WL Med J Aust; 2009 Dec 7-21; 191(11-12):648-52. PubMed ID: 20028294 [TBL] [Abstract][Full Text] [Related]
40. Researcher, research thyself? Mapping the landscape of canine health and welfare research funding provided by UK not-for-profit organisations from 2012-2022. Skipper AM; Packer RMA; O'Neill DG PLoS One; 2024; 19(5):e0303498. PubMed ID: 38781269 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]